Early Research on LSD for Alcohol Problems: A Look at State Mental Hospitals and Elsewhere By Kenneth Anderson, MA In the 1950s, researchers such as Humphry Osmond and Abram Hoffer in Saskatchewan, Canada developed a unique therapy for alcoholism which entailed using a psychedelic experience to alter the beliefs and values of the alcoholic patients. Set and setting were essential variables in successfully inducing a psychedelic experience. The term "set" refers to the internal mindset of the person about to undergo the psychedelic experience. Patients were given weeks of psychological preparation by the researchers before they were given LSD, in order to ensure that they had the proper mindset for a positive and life-altering psychedelic experience. The term "setting" referred to th...

by Thaddeus Camlin, PsyD The glare cast from the hot spotlight on the Presidential Election drowned out what is arguably the single best day for drug policy reform in U.S. history.  Oregon became the first state to both decriminalize drugs and legalize psilocybin treatment. Four additional U.S. states legalized recreational cannabis.  All drug policy reform propositions up for vote in 2020 passed.  Even in South Dakota, where many believed recreational cannabis would not be legalized, voters chose to put an end to charging people with pot felonies that strip voting rights and rob employment opportunities.  Hope for meaningful drug policy reform is abundant and calls for federal reform are gaining steam. The legalization of psilocybin treatment in Oregon will take about two yea...

by Thaddeus Camlin, PsyD Few things scare big pharma like effective medicines people don’t have to take every day.  Many are familiar with the sardonic notion that there is no money in the cure.  The psychedelic treatment renaissance is arguably the biggest existential threat to big pharma’s decades-long chokehold on America’s addiction to psychotropic medications.  Patents on naturally occurring alkaloids are not permitted in the U.S., so for those looking to capitalize on the resurgence of effective plant medicines creative strategies must be employed.  Enter psilocybin sublingual strips.  A Toronto based company recently announced its efforts to develop a patentable delivery mechanism for the psychoactive compounds in magic mushrooms, namely, psilocybin and psilocyn.  Administ...

by Thaddeus Camlin, PsyD Good news for people interested in effective treatment innovations, Oregon recently set the stage to legalize mushroom therapy for addiction.  The measure will be on the ballot for voters in the fall of 2020, and if passed, Oregon could be the first state to legally offer psilocybin treatment.  Years later, our first piece on mushroom therapy for addiction remains one of our most heavily trafficked editorials.  Thanks to the intrepid spirit of Oregonian voters, the days of jetting off to mycology retreat centers in paradisian locations with legal grey areas on drug policies and paying tens of thousands of dollars for psilocybin treatment may be coming to a close sooner than expected. Research continues to mount in support of mushroom therapy for addict...

by Thaddeus Camlin, Psy.D. Research chemicals are commonly associated with things like ‘the dark web,’ ‘silk road,’ ‘the amazon of drugs,’ and other, slightly shady and un-salubrious sectors of society.  However, research chemicals earn their family name because there are some actual scientific researchers investigating true therapeutic and clinical potential.  Recently, one such scientific researcher, Dr. Alan Kozilowski, a trained organic chemist from the University of Berkeley and Harvard, outlined his efforts to manufacture a compound that mirrors the effects of psilocybin.     Psilocybin is a compound best know for being the ‘magic’ in the mushroom.  Kozilowski was inspired by the significant, positive research findings for psilocybin and the treatment of various ...

by Thaddeus Camlin, Psy.D. Addiction treatment outcomes in the United States leave much to be desired.  Most US addiction treatment is not evidence based. The time for easy access to varied, effective options in addiction treatment is long overdue.  A recent study in Nature, one of the world’s most prestigious scientific journals, shows that ketamine can effectively reduce harmful drinking, especially when ketamine is given immediately following the induction of a craving.  After a single session of what could be described as ketamine-assisted cue-exposure treatment, participants’ drinking frequency and intensity reduced rapidly and remained at about ½ of original consumption levels at a nine-month follow-up.  The study in Nature calls for further research into ketamine therapy a...

by Thaddeus Camlin, Psy.D. They said acid fries your brain and makes you jump off buildings.  They said shrooms make your brain bleed and that’s why they cause hallucinations.  They said pot makes people murder their families.  I don’t know exactly who ‘they’ are, but boy were they wrong.  The prestigious Johns Hopkins University just announced the opening of a nearly $20 million dollar research center to study psychedelic medicines.  The announcement from Johns Hopkins is arguably the single biggest acknowledgment that Western Society has been embarrassingly wrong about psychedelics all along.  Support for Psychedelic Therapy Research trials forthcoming from the new research center include the use of psychedelics to treat addiction, anorexia, Alzheimer’s related distress and cogni...

by Thaddeus Camlin, Psy.D. When it comes to addiction treatment, it is well-known that the United States is embarrassingly and shamefully behind the rest of the industrialized world.  It is no surprise then that evidence for MDMA-assisted psychotherapy reducing alcohol relapse is coming out of the UK. We know MDMA-assisted psychotherapy was designated breakthrough status as a treatment for PTSD, and we know that trauma is at the etiological heart of most addictive behaviors (see Atkins, 2014, p.195). So it would naturally follow that if MDMA-Assisted Psychotherapy helps treat the etiology of addiction, it will probably help treat addiction. Yet, the misinformed notion that all addicts are the same and can never touch mind-altering substances again (except of course for boat-loads...

by Thaddeus Camlin, Psy.D. Possession of psychoactive fungus is no longer a crime in Denver, Colorado.  Denver's decriminalization of psilocybin (the magic in magic mushrooms) is a major step forward in efforts to end the disastrous drug war, failed prohibition efforts, and the injustice of mass incarceration. Decriminalizing psilocybin is also a major step forward in advancing the use of psychedelics to improve treatment for numerous issues including anxiety, depression, PTSD, OCD, and addiction.  In light of Denver’s bold and courageous move, this week let us consider the idea that psychedelics in general, and psilocybin specifically, might advance the quality of medical and mental health care significantly. Magic Mushrooms Have a Place in Medicine Mushroom therapy for addict...

by Thaddeus Camlin, Psy.D. Evidence continues to mount in support of safe, effective treatment assisted with psychedelics. States like Oregon, Colorado, and Washington are preparing to vote on the legalization of psilocybin in the near future, a psychedelic with a wide array of healing potentials. MDMA earned 'breakthrough status' from the FDA and is set to be the leading treatment for PTSD by 2021. However, quietly, and before the forerunners of psilocybin and MDMA, ketamine already emerged and is currently being implemented in safe, legal treatment across the United States. Ketamine's Place in the Treatment of Addiction Ketamine reliably and quickly alleviates severe depressive symptoms.  Many ER hospitals currently treat people who are actively suicidal with ketamine, and often ...